aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in 2009 and based in Solana Beach, California, Spinnaker Biosciences is a biotechnology company specializing in ophthalmic drug delivery technologies. The company's core mission is to innovate and improve drug delivery systems for eye-related treatments, leveraging advanced materials such as porous silicon, porous silicon oxide, and porous silicon/polymer composites. These materials are designed with unique optical, chemical, and structural features to enhance the efficacy and precision of drug delivery. Spinnaker Biosciences also explores applications in oncology and other medical fields.
Notable individuals affiliated with Spinnaker Biosciences include its founders, who have significant expertise in biotechnology and material sciences. The company has garnered attention from investors interested in cutting-edge medical technologies. Key achievements include the development of fusogenic liposome-coated nanoparticles, which have potential applications beyond ophthalmology. Overall, Spinnaker Biosciences has made a significant impact by advancing drug delivery technologies, particularly in the field of ophthalmology, contributing to more effective and targeted treatments.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Drug Delivery
Technology
Biotech
Tags
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
HealthTech
Geographic Exposure
United States
When was Spinnaker Biosciences founded?
Spinnaker Biosciences was founded in 2009.
Where is Spinnaker Biosciences’s headquarters located?
Spinnaker Biosciences’s headquarters is located in Solana Beach, CA, US.
When was Spinnaker Biosciences’s last funding round?
Spinnaker Biosciences’s most recent funding round was for $900k (USD) in May 2015.
How many employees does Spinnaker Biosciences have?
Spinnaker Biosciences has 30 employees as of Feb 5, 2024.
How much has Spinnaker Biosciences raised to-date?
As of July 05, 2023, Spinnaker Biosciences has raised a total of $1.9M (USD) since May 29, 2015.
Add Comparison
Total Raised to Date
$1.9M
USD
Last Update May 29, 2015
Last Deal Details
$900k
USD
May 29, 2015
Series Unknown
Total Employees Over Time
30
As of Feb 2024
Spinnaker Biosciences Address
665 San Rodolfo Drive
suite 124/165
Solana Beach,
California
92075
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts